- The new product is offered exclusively by Brenntag Beauty & Personal Care globally and will be launched at the in-cosmetics global in Paris in April 2026
- Insempra's biotechnology-derived Omega-7 biolipid is the first of multiple products planned under a broader strategic collaboration
Brenntag, the global market leader in chemicals and ingredients distribution, today announced an exclusive distribution agreement with Insempra, the industrial biotechnology company pioneering next-generation bio-based ingredients, to bring Insempra's innovative Omega-7 biolipid to global Beauty & Personal Care markets.
Brenntag is expanding its own-brand portfolio with a next-generation biotech ingredient that reflects the future of sustainable beauty. CosVivetTM ActiLipid O7 is a next-generation biotech biolipid that unites active performance, multifunctionality and sustainability in one powerful ingredient while additionally delivering premium sensory experience. It is based on Insempra's Omega-7 biolipid, which is designed to meet demand for high-performance, sustainable beauty solutions.
Lipids are essential for skin barrier strength, hydration and elasticity and key to skin health, moisture retention and soothing. With its high omega-7 content and unique composition, CosVivetTM ActiLipid O7 has been developed to support moisturization and help maintain smooth, supple-looking skin, making it particularly suitable for sensitive and delicate skin care applications. CosVivetTM ActiLipid O7 combines multifunctional performance with a refined sensory profile, contributing to a silky, lightweight and non-greasy skin feel, effortless spreadability and an elegant finish. It is fully oil-soluble, compatible with lipophilic raw materials and offers formulation flexibility across a wide range of skin care concepts. Produced through an advanced fermentation process, CosVivetTM ActiLipid O7 aligns with evolving sustainability expectations and supports responsible beauty innovation.
CosVivetTM ActiLipid O7 is a clear yellow liquid with minimal odour, high thermal stability and minimal impact on odour and colours in finished formulations. It is fully soluble in oils, compatible with liposoluble raw materials and an alternative to oils like sea buckthorn and macadamia without heir variability issues. Produced through precision fermentation, it features a strong environmental profile, aligned with modern sustainability expectations and therefore enables the creation of products that combine effective performance with environmental responsibility.
Michael Wilkop, Brenntag Specialties Regional President Beauty & Care EMEA, states: “We are excited to embark on this new offer which underscores our commitment to helping our customers access cutting-edge sustainable ingredients that meet evolving consumer demands. Insempra's expertise in industrial biotechnology combined with Brenntag's global distribution network, technical capabilities, and Innovation and Application Centers creates a powerful platform for delivering sustainable beauty solutions. This is the first of several innovative products we plan to introduce together.”
Jens Klein, CEO and Founder of Insempra, added: "This distribution agreement with Brenntag represents a pivotal moment for Insempra as we scale our biotechnology innovations to reach the global beauty industry. Brenntag's unparalleled market reach, deep technical expertise, and commitment to sustainability make them the ideal partner to bring our Omega-7 biolipid and future products to market. This is only the beginning - we are already developing additional breakthrough ingredients that will continue to transform the beauty and personal care industry."
To learn more about CosVivet ActiLipid O7 and Brenntag’s approach to responsible innovation, Brenntag invites customers and partners to join the presentation ‘Next-generation fermented biolipid for advanced beauty performance and environmental responsibility’ at the in-cosmetics Global in Paris on Wednesday, 15 April, 13:45 – 14:15 at the Sustainability Zone Theatre, Hall 7, Level 1 (booth 1C100).
About Insempra:
Insempra is an industrial biotechnology company enabling industries to create superior products in harmony with nature. By combining advanced bioscience with scalable manufacturing technologies, Insempra delivers high-performance specialty ingredients through precision fermentation. For decades, industries have relied on chemical production processes and petrochemical-derived inputs, depleting our planet's limited resources. Insempra is driving the shift toward industrial-scale bio-manufacturing – combining supply chain resilience while reducing environmental impact. With a multidisciplinary team of biologists, engineers, and entrepreneurs, Insempra is building the next generation of specialty ingredient manufacturing. For more information, visit www.insempra.bio.
